Flutiform 50mcg/5mcg（丙酸氟替卡松/富马酸福莫特罗吸入懸浮剂） - 哮喘药物

TOP

Flutiform 50mcg/5mcg（丙酸氟替卡松/富马酸福莫特罗吸入懸浮剂）

药店国别：

产地国家：

澳大利亚

处方药：

是

所属类别：

50微克/5微克 120剂量吸入气雾剂

包装规格：

50微克/5微克 120剂量吸入气雾剂

计价单位：

生产厂家中文参考译名:

Mundipharma Pty Ltd

生产厂家英文名:

Mundipharma Pty Ltd

该药品相关信息网址1:

http://www.flutiform.com/

该药品相关信息网址2:

该药品相关信息网址3:

原产地英文商品名:

Flutiform 50mcg/5mcg MDI 120 doses Inhaler

原产地英文药品名:

Fluticasone Propionate/Formoterol Fumarate

中文参考商品译名:

Flutiform 50微克/5微克 120剂量吸入气雾剂

中文参考药品译名:

丙酸氟替卡松/富马酸福莫特罗

曾用名:

简介：

部份中文丙酸氟替卡松/富马酸福莫特罗资料（仅供参考）
新的用于哮喘的维持治疗的组合疗法—flutiform（丙酸氟替卡松/富马酸福莫特罗）获批上市。
Flutiform由吸入皮质类固醇（ICS）氟替卡松（fluticasone）与长效β2-受体激动剂（LABA）福莫特罗（formoterol）组成，通过一个单一的气雾吸入器给药，是目前第一个该组合的药物，该组合治疗方法
产品描述
flutiform 50mcg/5mcg，125mcg/5mcg和250mcg/10mcg固定剂量组合的丙酸氟替卡松和富马酸福莫特罗（flutiform吸入器）是组成。
•治疗哮喘，使用相结合的制品（安inhaled corticosteroid速效β2受体激动剂和一个长）是appr不恰当的：
•为患者充分控与inhaled corticosteroids和AS要求我inhaled短- 2激动剂的作用。
•为患者或已经充分控在安inhaled corticosteroid都和一个长2受体激动剂的作用。flutiform吸入器是显示在成人和青少年年龄12岁及以上。

Product Description
flutiform 50mcg/5mcg, 125mcg/5mcg and 250mcg/10mcg fixed-dose combinations of fluticasone propionate and formoterol fumarate (Flutiform inhaler)are indicated in the regular treatment of asthma where the use of a combination product (an inhaled corticosteroid and a long-acting beta2 agonist) is appropriate: • For patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting 2 agonist. Or • For patients already adequately controlled on both an inhaled corticosteroid and a long-acting 2 agonist. Flutiform inhalers are indicated in adults and adolescents aged 12 years and above.